GetTopicDetailResponse(id=e44b11816178, topicName=單倍體移植, introduction=, content=AML 單倍體移植, image=null, comments=0, allHits=895, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Aug 21 13:35:05 CST 2024, time=2024-08-21, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=494691, tagList=[TagDto(tagId=494691, tagName=單倍體移植)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2235422, encodeId=c77c223542233, content=<a href='/topic/show?id=3146892e7c7' target=_blank style='color:#2F92EE;'>#血液惡性腫瘤#</a> <a href='/topic/show?id=e44b11816178' target=_blank style='color:#2F92EE;'>#單倍體移植#</a>, objectTitle=?黃曉軍院士牽頭研究對比三種單倍體移植方案，證實G-CSF/ATG更優(yōu), objectType=article, longId=849943, objectId=c07d84994329, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241104/1730697378429_8538692.png, objectUrl=/article/show_article.do?id=c07d84994329, replyNumber=0, likeNumber=77, createdTime=2024-11-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c07d84994329, moduleTitle=?黃曉軍院士牽頭研究對比三種單倍體移植方案，證實G-CSF/ATG更優(yōu), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c07d84994329)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231981, encodeId=27c12231981fe, content=<a href='/topic/show?id=850849e666e' target=_blank style='color:#2F92EE;'>#異基因造血干細胞移植#</a> <a href='/topic/show?id=62401203584b' target=_blank style='color:#2F92EE;'>#非體外去T細胞#</a> <a href='/topic/show?id=e44b11816178' target=_blank style='color:#2F92EE;'>#單倍體移植#</a> <a href='/topic/show?id=c52e1203591a' target=_blank style='color:#2F92EE;'>#ATLG#</a> <a href='/topic/show?id=881612036067' target=_blank style='color:#2F92EE;'>#ATG#</a>, objectTitle=【BMT】單倍體移植新型預處理方案：ATLG替代ATG用于非體外去T細胞, objectType=article, longId=847722, objectId=88e584e72249, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240717/1721215125958_8538692.jpg, objectUrl=/article/show_article.do?id=88e584e72249, replyNumber=0, likeNumber=78, createdTime=2024-10-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=88e584e72249, moduleTitle=【BMT】單倍體移植新型預處理方案：ATLG替代ATG用于非體外去T細胞, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=88e584e72249)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221699, encodeId=40a52221699fe, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=e44b11816178' target=_blank style='color:#2F92EE;'>#單倍體移植#</a>, objectTitle=Blood Adv：原發(fā)難治/復發(fā)性繼發(fā)性AML預后較差，單倍體移植或許是新的機會, objectType=article, longId=839645, objectId=f8ff8396452e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721281386020_92910.jpg, objectUrl=/article/show_article.do?id=f8ff8396452e, replyNumber=0, likeNumber=275, createdTime=2024-08-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f8ff8396452e, moduleTitle=Blood Adv：原發(fā)難治/復發(fā)性繼發(fā)性AML預后較差，單倍體移植或許是新的機會, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f8ff8396452e)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-08-21發(fā)表于上海
